Share on StockTwits

Petmed Express (NASDAQ:PETS) Director Ronald J. Korn sold 2,000 shares of Petmed Express stock on the open market in a transaction dated Friday, August 15th. The stock was sold at an average price of $14.13, for a total value of $28,260.00. Following the transaction, the director now directly owns 78,333 shares of the company’s stock, valued at approximately $1,106,845. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Petmed Express (NASDAQ:PETS) traded up 0.71% during mid-day trading on Wednesday, hitting $14.25. 49,974 shares of the company’s stock traded hands. Petmed Express has a one year low of $12.13 and a one year high of $17.21. The stock’s 50-day moving average is $13.80 and its 200-day moving average is $13.41. The company has a market cap of $284.4 million and a price-to-earnings ratio of 15.55.

Petmed Express (NASDAQ:PETS) last announced its earnings results on Monday, July 21st. The company reported $0.25 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.25. The company had revenue of $72.50 million for the quarter, compared to the consensus estimate of $74.25 million. During the same quarter last year, the company posted $0.24 earnings per share. Petmed Express’s revenue was down 2.3% compared to the same quarter last year. Analysts expect that Petmed Express will post $0.91 EPS for the current fiscal year.

Separately, analysts at Zacks reiterated a “neutral” rating on shares of Petmed Express in a research note on Friday, July 25th. They now have a $15.00 price target on the stock.

PetMed Express, Inc (NASDAQ:PETS) and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.